Skip to main content
| News

AMR Action Fund opens European office in Basel

07.02.2022

The AMR Action Fund has moved into its new European office in Basel. The venture fund is the largest public-private partnership for the development of novel antibiotics. As a result, the Basel Area now boasts a reputable newcomer to bolster its reputation as a European center in the fight against antibiotic resistance.

Messeturm Basel
AMR Action Fund is based at the Messeturm Basel (img: FlexOffice)

The AMR Action Fund has opened its European office at FlexOffice at the Messeturm Basel. According to information from the company itself, the fund, which is headquartered in Boston in the USA, is the world’s largest public-private partnership (PPP) investing in the development of novel antibiotics. Alongside numerous reputable pharma groups, the Basel-based heavyweights Roche and Novartis are among the fund’s investors. The investment and innovation promotion agency Basel Area Business & Innovation supported the AMR Action Fund’s move to Basel.

“Basel has long been a hub of biopharmaceutical innovation”, comments Martin Heidecker, Chief Investment Officer of the fund, in a press release. “Establishing a presence within the city will allow the fund to operate and identify promising investment opportunities on a truly global scale”, he adds.

In order to address the growing threat of antibiotic resistance and improve market conditions, the fund will invest around one billion US dollars in clinical-stage biotech companies with the overarching aim of bringing two to four antimicrobial drugs to the market. “Expanding our presence to Basel is good for the fund and good for the antibiotics research ecosystem in general”, explains CEO Henry Skinner.

Strong network to combat antimicrobial resistance

The fund will benefit from the fact that intensive research in the area of drugs to combat antimicrobial resistance is already being carried out in the Basel Area. For example, the INCATE and NCCR AntiResist initiatives are already established in the city, in addition to the Spearhead project. The Swiss National Center of Competence in Research (NCCR) AntiResist is financed by the Swiss National Science Foundation and sponsored by the University of Basel. For its part, the innovation incubator INCATE (Incubator for Antibacterial Therapies in Europe) is a partnership between NCCR AntiResist, the University of Basel’s innovation office and two German consortiums with four industrial partners. Spearhead, a consortium that consists of eight public and four private Swiss institutions, is likewise focused on finding solutions to the silent pandemic of antimicrobial resistance.

You may also be interested in

Novartis investing 100 million Swiss francs in new biologics center
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Novartis investing 100 million Swiss francs in new biologics center

The pharmaceutical company Novartis is investing a sum of 100 million Swiss francs in a new competence center for biologics...

Read More
Official opening of the competence center uptownBasel
Basel Area Business & Innovation, ICT, Innovation, Invest

Official opening of the competence center uptownBasel

uptownBasel celebrated its official opening. Technology companies such as Bouygues and Vinci Energies are already occupying the first building of...

Read More
Eight startups from Basel Area feature in TOP 100 Swiss Startups
Basel Area Business & Innovation, Innovation, Life Sciences / biotech, Medtech, Switzerland Innovation Park

Eight startups from Basel Area feature in TOP 100 Swiss Startups

Among the most promising startups in Switzerland eight companies from Basel Area's startup ecosystem have been named. They are some...

Read More
Roche opens tallest building in Switzerland
Basel Area Business & Innovation, Invest, Life Sciences / biotech

Roche opens tallest building in Switzerland

Roche has inaugurated a new office building with 3,200 positions in Basel. Standing 205 meters high, Building 2 is the...

Read More
DayOne Tech supports three medtech startups
Basel Area Business & Innovation, Innovation, Medtech, Switzerland Innovation Park

DayOne Tech supports three medtech startups

DayOne, the healthcare innovation initiative from Basel Area Business & Innovation, has started its medtech accelerator in the canton of...

Read More
Basel Area achieves milestone with settling of LifeMine
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Basel Area achieves milestone with settling of LifeMine

Life sciences company LifeMine Therapeutics from the USA has established its European headquarters in the Basel Area. With this, Basel...

Read More
1 2 3 37